OKYO Pharma financials at a glance
| Year | Year | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2008 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$10.26M | $2.81M | $-13.07M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| OM | Operating Margin |
|
87.15% | 77.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$0.00 | |||||||||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
66.15m | 66.15m | 71.11m | 92.04m | 4.43m | 4.45m | 5.8m | 5.86m | 5.86m | 5.86m | 523.6m | 560.47m | 10.35m | 0m | 14.93m | 21.77m | 33.24m | 0m |
| OCF | Operating Cash Flow |
|
$-0.16M | $-0.58M | $-0.81M | $-2.92M | $-2.52M | $-2.07M | $-0.96M | $-0.45M | $-0.52M | $-1.14M | $-1.53M | $-1.07M | $-1.24M | $-0.35M | $-3.98M | $-7.70M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $-3.20M | $-2.80M | $-2.23M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-1.25M | $0.00M | $0.00M | $-7.71M | $0.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.01 | $-0.01 | $-0.01 | $-0.03 | $-0.01 | $-0.01 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.03 | $-0.00 | $-0.35 | $0.00 | $0.00 |